載入...
Scleroderma patients with antibodies against the large subunits of both RNA polymerases-I and -III are protected against cancer
OBJECTIVES: While compelling data suggest a cancer-induced autoimmunity model in scleroderma patients with anti-RNA polymerase III large subunit (anti-RPC155) antibodies, ~85% of these patients do not manifest cancer. We hypothesized that anti-RPC155-positive scleroderma patients without detectable...
Na minha lista:
| 發表在: | Arthritis Rheumatol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6717013/ https://ncbi.nlm.nih.gov/pubmed/30888702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40893 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|